A Pilot Study of Sensation-Focused Intensive Treatment for Panic Disorder With Moderate to Severe Agoraphobia: Preliminary Outcome and Benchmarking Data

MA, Center for Anxiety and Related Disorders, Boston University, Botson, MA 02215, USA.
Behavior modification (Impact Factor: 2.23). 04/2008; 32(2):196-214. DOI: 10.1177/0145445507309019
Source: PubMed


This report presents results of a treatment for panic disorder with moderate to severe agoraphobia (PDA-MS) called sensation-focused intensive treatment (SFIT). SFIT is an 8-day intensive treatment that combines features of cognitive- behavioral treatment for panic disorder, such as interoceptive exposure and cognitive restructuring with ungraded situational exposure. SFIT focuses on feared physical sensations as well as agoraphobic avoidance. Preliminary data support the utility of SFIT in improving PDA-MS. The goal of this exploratory study was to further investigate the effectiveness of SFIT and evaluate factors related to treatment outcome, including severity of panic symptoms, gender, comorbidity, self-efficacy, and place of residence (local vs. remote). SFIT was found to be effective in decreasing panic symptoms from pre- to posttreatment, with treatment gains maintained at follow-up. The implications of these findings for the treatment of PDA are discussed.

Download full-text


Available from: Sandra B Morissette, Feb 16, 2015
1 Follower
24 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Podeu consultar la versió anterior a: Se abordan diversos aspectos de la agorafobia y el trastorno de pánico: naturaleza, edad de comienzo y curso, frecuencia, problemas asociados, génesis y mantenimiento, métodos e instrumentos de evaluación, y eficacia y utilidad clínica del tratamiento psicológico y farmacológico. Además, se ofrecen guías para aplicar los tratamientos psicológicos más eficaces.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Panic disorder is a commonly encountered condition in general medical practice and in various medical settings. It is important for all medical practitioners to be able to recognize this disorder, provide patients with basic information and medical advice, and depending on the specific circumstances, to refer patients for appropriate treatment by primary care physicians, psychiatrists and/or clinical psychologists. This article reviews the developments in the treatment of panic disorder, focusing on the major treatment modalities of pharmacotherapy and cognitive-behavior therapy, as well as their combinations. In addition to providing information on current treatments for panic disorder and the main underlying treatment issues, the article identifies areas where improvements need to be made and areas where much research has been conducted in recent years. These include simplified modes of delivery of cognitive-behavior therapy, optimal ways of combining medications with cognitive-behavior therapy, and minimizing the risk of recurrence after the cessation of treatment.
    Expert Review of Neurotherapeutics 09/2008; 8(8):1219-32. DOI:10.1586/14737175.8.8.1219 · 2.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The present review summarizes empirical developments in the psychosocial treatment of panic and panic disorder by focusing on four key themes that have been emphasized in this literature: (a) treatment efficacy, effectiveness, and innovation; (b) modulating and process variables in treatment; (c) effective dissemination of treatment; and (d) prevention of panic. Cognitive behavioral treatments (CBTs) for panic are very good, even in the context of comorbidity, but the level of efficacy does not appear to be increasing over time. Unfortunately, there have been relatively few substantive innovations in CBT protocols since the 1980s, and despite progress in the use of computer technology, dissemination of these treatments is lagging. The prevention of panic-spectrum psychopathology is a promising area linked with advances in the identification of panic-relevant risk factors that appear to modulate CBT outcomes.
    Annual Review of Clinical Psychology 12/2009; 6(1):241-56. DOI:10.1146/annurev.clinpsy.121208.131317 · 12.67 Impact Factor
Show more